INMED PHARMACEUTICALS INC (INM) Stock Income Statement
NASDAQ:INM - Nasdaq - CA4576377002 - Common Stock - Currency: USD
| TTM (2024-12-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.83M | 4.60M | 4.14M | 1.09M | 0.00 | |||
| Cost Of Goods | 3.12M | 3.50M | 2.73M | 550.00K | N/A | |||
| Gross Profit | 1.71M | 1.10M | 1.40M | 540.00K | N/A | |||
| Operating Expenses | 9.48M | 9.24M | 9.78M | 14.13M | 9.94M | |||
| Research and Development | 3.59M | 3.77M | 3.73M | 7.28M | 5.34M | |||
| Selling, General, and Administrative Expenses | 5.56M | 5.25M | 5.85M | 6.67M | 4.48M | |||
| Operating Income | -7.77M | -8.13M | -8.38M | -13.59M | -9.94M | |||
| Interest Income/Expense | -140.70K | 466.00K | 440.00K | -20.00K | 100.00K | |||
| Other Income/Expense | N/A | N/A | N/A | -1.31M | -360.00K | |||
| Non Recurring Items | N/A | N/A | N/A | -3.67M | N/A | |||
| Income Before Taxes | -7.91M | -7.67M | -7.93M | -18.60M | -10.20M | |||
| Income Tax | 7.10K | 7.10K | 10.00K | N/A | N/A | |||
| Net Income | -7.91M | -7.68M | -7.95M | -18.60M | -10.20M | |||
| EBITDA | -7.55M | -7.91M | -8.18M | -13.40M | -9.82M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -13.97 | -20.14 | -3.25 | -33.21 | -37.77 | |||
| Non GAAP EPS | N/A | N/A | N/A | -34.28 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 35.39% | 23.94% | 33.82% | 49.54% | N/A | |||
| Profit Margin | -163.77% | -166.94% | -192.03% | -1706.42% | N/A | |||
| Operating Profit Margin | -160.72% | -176.92% | -202.42% | -1246.79% | N/A | |||
All data in USD